Vaccine Priming of Rare HIV Broadly Neutralizing Antibody Precursors in Nonhuman Primates
Authors
Affiliations
Germline-targeting immunogens hold promise for initiating the induction of broadly neutralizing antibodies (bnAbs) to HIV and other pathogens. However, antibody-antigen recognition is typically dominated by heavy chain complementarity determining region 3 (HCDR3) interactions, and vaccine priming of HCDR3-dominant bnAbs by germline-targeting immunogens has not been demonstrated in humans or outbred animals. In this work, immunization with N332-GT5, an HIV envelope trimer designed to target precursors of the HCDR3-dominant bnAb BG18, primed bnAb-precursor B cells in eight of eight rhesus macaques to substantial frequencies and with diverse lineages in germinal center and memory B cells. We confirmed bnAb-mimicking, HCDR3-dominant, trimer-binding interactions with cryo-electron microscopy. Our results demonstrate proof of principle for HCDR3-dominant bnAb-precursor priming in outbred animals and suggest that N332-GT5 holds promise for the induction of similar responses in humans.
Ramezani-Rad P, Cottrell C, Marina-Zarate E, Liguori A, Landais E, Torres J bioRxiv. 2025; .
PMID: 39896562 PMC: 11785158. DOI: 10.1101/2025.01.24.634423.
Broadly inhibitory antibodies to severe malaria virulence proteins.
Reyes R, Raghavan S, Hurlburt N, Introini V, Bol S, Kana I Nature. 2024; 636(8041):182-189.
PMID: 39567685 DOI: 10.1038/s41586-024-08220-3.
HIV Vaccine Development at a Crossroads: New B and T Cell Approaches.
Govindan R, Stephenson K Vaccines (Basel). 2024; 12(9).
PMID: 39340073 PMC: 11435826. DOI: 10.3390/vaccines12091043.
Bhagchandani S, Yang L, Lam J, Maiorino L, Ben-Akiva E, Rodrigues K Sci Immunol. 2024; 9(99):eadl3755.
PMID: 39303017 PMC: 11492009. DOI: 10.1126/sciimmunol.adl3755.
Wang X, Cottrell C, Hu X, Ray R, Bottermann M, Villavicencio P Sci Immunol. 2024; 9(95):eadn0622.
PMID: 38753808 PMC: 11488661. DOI: 10.1126/sciimmunol.adn0622.